| 000 | 01486 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250512043900.0 | ||
| 264 | 0 | _c19900725 | |
| 008 | 199007s 0 0 eng d | ||
| 022 | _a0041-1345 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCanafax, D M | |
| 245 | 0 | 0 |
_aCox regression analysis of outcome risk factors in 519 renal allograft recipients. _h[electronic resource] |
| 260 |
_bTransplantation proceedings _cFeb 1987 |
||
| 300 |
_a1947-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntilymphocyte Serum _xtherapeutic use |
| 650 | 0 | 4 |
_aAzathioprine _xtherapeutic use |
| 650 | 0 | 4 |
_aCyclosporins _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aGraft Survival |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunosuppression Therapy |
| 650 | 0 | 4 |
_aKidney Transplantation _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPrednisone _xtherapeutic use |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRegression Analysis |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 700 | 1 | _aSavik, S K | |
| 700 | 1 | _aDraxler, C A | |
| 700 | 1 | _aLe, C T | |
| 700 | 1 | _aAscher, N L | |
| 700 | 1 | _aPayne, W D | |
| 700 | 1 | _aSutherland, D E | |
| 700 | 1 | _aMigliori, R J | |
| 700 | 1 | _aSimmons, R L | |
| 700 | 1 | _aNajarian, J S | |
| 773 | 0 |
_tTransplantation proceedings _gvol. 19 _gno. 1 Pt 3 _gp. 1947-8 |
|
| 999 |
_c3280219 _d3280219 |
||